Viking Therapeutics has launched Part 2 of a study exploring oral and subcutaneous dosing regimens of VK2735, a dual GLP-1/GIP receptor agonist, to maintain weight loss in adults with obesity. This randomized, placebo-controlled trial follows positive results from Part 1, which tested subcutaneous doses. The study aims to find flexible maintenance options to improve long-term adherence and weight management, with results expected in 2027. Viking is also conducting two Phase 3 trials assessing weekly subcutaneous VK2735 for obesity treatment.
Viking Therapeutics' new clinical trial on VK2735 oral maintenance dosing is noted here with Pluang's Health sector market data as of Oct 06, 2026 17:51 WIB. Of 100 priced Health-sector US stocks tradable on Pluang, 67 rose and 25 fell today. Notable movers include TXG at USD 100.73 with a 1-day change of +3.06% and a typical hold time of 93 days, and TWST at USD 209.30 with a 1-day change of +2.10% but with 92% sell order activity. The most notable figure is TXG's 73% buy order activity.
Over the past six months, Costco's stock has fallen by 10%, contrasting with the S&P 500's 17% gain. This decline has sparked debate on whether Costco's shares, now trading under $900, represent a buying opportunity. Investors are weighing if the pri...
Elon Musk has confirmed that his company is in discussions with Terafab, marking a potential new chip manufacturing partner alongside Intel, which has been the only named chip partner until now. This development could diversify the supply chain and e...
SpaceX stock surged over 17% recently, trading near $173.30 as of October 6, 2026. Goldman Sachs raised its 12-month price target to $230, expecting a 32.7% upside driven by strong AI segment growth and expanding space opportunities. Morgan Stanley a...
Barrick Gold resolved its dispute with Newmont, receiving a $1.95 billion payment and approval to list its North American gold assets separately. This move aims to unlock hidden value, particularly in Nevada, while leaving African and copper assets o...
Hyperscale Data held about $18.5 million in Bitcoin and $37.5 million in cash as of late September, totaling $56 million in assets, which is 153% of its market cap. The company stopped Bitcoin mining at its Michigan facility on September 1 to convert...
